돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HCID 145613생성일: 2026년 11월 5일

2-Fluoro-6-(trifluoromethyl)benzonitrile

2-CYANO-3-FLUOROBENZOTRIFLUORIDE · 3-fluoro-2-cyanobenzotrifluoride · α,α,α,6-tetrafluoro-o-tolunitrile · à,à,à,6-tetrafluoro-o-tolunitrile · 2-Fluoro-6-(trifluoromethyl)benzonitrile · Benzonitrile, 2-fluoro-6-(trifluoromethyl)- · 2-Fluoro-6-(trifluoromethyl)benzonitrile>2-Cyano-1-fluoro-3-(trifluoromethyl)benzene · 2-Fluoro-6-(trifluoromethyl)benzonitrile97%

https://huagongshe.com/ko/chemical/145613

2-Fluoro-6-(trifluoromethyl)benzonitrile 분자 구조식

식별자 및 물리적 특성

CAS No.133116-83-3
분자식C8H3F4N
평균 분자량189.11 g/mol
단동위원소 질량189.02016198 g/mol
SMILESN#Cc1c(F)cccc1C(F)(F)F
InChIKeyOGQYJDHTHFAPRN-UHFFFAOYSA-N
PubChem CID145613
EC No.627-838-5
DTXSIDDTXSID70157959

화학 및 물리적 성질

XLogP2.6
극성 표면적23.8
수소 결합 공여자 수0
수소 결합 수용자 수5
회전 가능 결합 수0
무거운 원자 수13
형식 전하0
복잡도226
녹는점26-28°C
끓는 점178°C (rough estimate)
밀도1.373 g/mL at 25 °C(lit.)
굴절률n20/D 1.452(lit.)
인화점210 °F
저장 조건Sealed in dry,Room Temperature
물리적 상태powder to lump
비중1.373
색상흰색에서 거의 흰색
BRN4312131
InChI1S/C8H3F4N/c9-7-3-1-2-6(5(7)4-13)8(10,11)12/h1-3H
InChIKeyOGQYJDHTHFAPRN-UHFFFAOYSA-N
SMILESFc1cccc(c1C#N)C(F)(F)F

안전 및 규제

GHS 분류WarningH302 (95.7%): Harmful if swallowed [Warning Acute toxicity, oral]P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 47 reports by companies from 7 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Hazard Classes and CategoriesAcute Tox. 4 (95.7%)
수질 위해 등급(WGK)3
운송 번호(UN)3276
관세 코드29269090
위험 문구(R)20/21/22-36/37/38
위험 표시Xn,T,Xi
안전 문구(S)26-36
포장분류III
위험 등급6.1Acute Tox. 4 DermalAcute Tox. 4 InhalationAcute Tox. 4 OralEye Irrit. 2Skin Irrit. 2STOT SE 3
위험 참고 사항Toxic
저장 분류10 - Combustible liquids

용도

용도

2-Fluoro-6-(trifluoromethyl)benzonitrile acts as a reagent in the synthesis of Quinolinecarboxamides for the treatment of autoimmune disorders.